Peanut Allergy-Focused Biotech May Strike Magic in Orlando

(Bloomberg) -- Aimmune Therapeutics Inc. is hoping to disrupt the potential multibillion dollar allergy desensitization market by taking advantage of competitor DBV Technologies SA’s failure in an ...

Bloomberg Quint

Add BloombergQuint App to Home screen.